Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - ACCOUNTS PAYABLE
Accounts Payable ABUS - Arbutus Biopharma Corporation
3.22 M
LAST VALUE
0.77%
2 YEAR CAGR
0.19%
5 YEAR CAGR
10.23%
10 YEAR CAGR